Results 91 to 100 of about 72,632 (272)

Prevalence and Risk Factors of Post‐Extraction Complications in a Western Australian Tertiary Dental Hospital: A Retrospective Cross‐Sectional Study

Australian Dental Journal, EarlyView.
ABSTRACT Objectives Dental extractions are routine procedures, yet they carry a risk of post‐operative complications that can negatively affect patients' quality of life. This study aimed to identify patient‐, tooth‐ and clinician‐related risk factors associated with post‐extraction complications at Western Australia's only tertiary dental hospital, to
Peter Dignam, Mariam Elshafey, Aparna Jeganathan, Magdalen Foo, Joon Soo Park, Manorika Ratnaweera   +5 more
wiley   +1 more source

Changes in Angiogenesis and Bone Turnover Markers in Patients with Gaucher Disease Developing Osteonecrosis

Metabolites
Background/Objectives: Patients with Gaucher disease have a high risk of bone disease, with osteonecrosis representing the most debilitating complication. The pathogenesis of osteonecrosis has not been fully elucidated yet, and there is an unmet need for
Simona D’Amore, Kenneth Eric Poole, Uma Ramaswami, Derralynn Hughes, Kathleen Page, Antonio Giovanni Solimando, Angelo Vacca, Timothy Martin Cox, Patrick Deegan   +8 more
doaj   +1 more source

Efficacy and Safety of Tenofovir Alafenamide (TAF) and Tenofovir Disoproxil Fumarate (TDF) Followed by TAF in Chronic Hepatitis B Patients of East Asian Ethnicity Following 5 Years of Treatment

Alimentary Pharmacology &Therapeutics, EarlyView.
In East Asian patients with chronic hepatitis B, rates of virologic suppression through 5 years were high in those treated continuously with tenofovir alafenamide (TAF) and in those switched from tenofovir disoproxil fumarate (TDF) to TAF. Improved renal and bone safety was observed in patients switching from TDF to TAF.
Grace Lai‐Hung Wong, Edward Gane, Calvin Q. Pan, Scott Fung, Mang M. Ma, Namiki Izumi, Shalimar, Seng Gee Lim, Wan‐Long Chuang, Rajiv Mehta, Young‐Suk Lim, Leland J. Yee, John F. Flaherty, Frida Abramov, Hongyuan Wang, Maria Buti   +15 more
wiley   +1 more source

Hip preserving surgery with concentrated autologous bone marrow aspirate transplantation for the treatment of asymptomatic osteonecrosis of the femoral head: retrospective review of clinical and radiological outcomes at 6 years postoperatively [PDF]

, 2017
BackgroundWe had previously established concentrated autologous bone marrow aspirate transplantation (CABMAT), a one-step, low-invasive, joint-preserving surgical technique for treating osteonecrosis of the femoral head (ONFH). The present study aimed to
Akaogi Hiroshi, Aoto Katsuya, Mishima Hajime, Sugaya Hisashi, Tomaru Yohei, Wada Hiroshi, Yamazaki Masashi, Yoshioka Tomokazu, 吉岡 友和   +8 more
core   +2 more sources

Long‐term outcome after allogeneic stem cell transplantation for GATA2 deficiency: An analysis of 67 adults and children from France and Belgium

British Journal of Haematology, EarlyView.
The overall survival of patients receiving an allogeneic haematopoietic stem cell transplant (HSCT) for GATA2 deficiency was significantly better if they were transplanted recently, with a bone marrow or cord blood graft and if the transplant was performed before the onset of excess blast. Excess blast before HSCT was the only factor associated with an
Flore Sicre de Fontbrune, Florian Chevillon, Mony Fahd, Kristell Desseaux, Xavier Poiré, Edouard Forcade, Arthur Sterin, Bénédicte Neven, Virginie Gandemer, Sylvain Thepot, Alice Garnier, Bruno Lioure, Ambroise Marcais, Stephanie Nguyen‐Quoc, Suzanne Tavitian, Laure Vincent, Jean Donadieu, Matthieu Resche Riggon, Sylvie Chevret, Marlene Pasquet, Regis Peffault de Latour   +20 more
wiley   +1 more source

Follow‐up of osteonecrosis in paediatric acute lymphoblastic leukaemia patients treated with the NOPHO ALL2008 protocol

British Journal of Haematology, EarlyView.
Summary Although osteonecrosis (ON) is a common sequel after childhood acute lymphoblastic leukaemia treatment and may cause debilitating symptoms, its prognosis remains underexplored. We describe the radiological evolution of ON lesions in a Finnish patient cohort treated according to the The Nordic Society of Paediatric Haematology and Oncology ...
Roosa Rokkanen, Henri Aarnivala, Sanna Huhtaniska, Sauli Palmu, Tytti Pokka, Tuuli Pöyhönen, Maria Suo‐Palosaari, Pauliina Utriainen, Liisa Järvelä, Riitta Niinimäki   +9 more
wiley   +1 more source

Asymptomatic multifocal avascular necrosis, a commonly overlooked finding in patients with systemic lupus erythematosus

BMC Rheumatology
Background In patients with Systemic lupus erythematosus (SLE), osteonecrosis of various joints is a debilitating complication associated with the disease and its treatment, in which a considerable proportion of osteonecrosis may be asymptomatic ...
Forough Nadi, Esmat Abdollahpour, Babak Fallahi, Leila Aghaghazvini, Majid Alikhani, Mohammad Nejadhosseinian, Seyedeh Tahereh Faezi   +6 more
doaj   +1 more source

Avascular Necrosis and Minimal Trauma Fractures in Telomere Biology Disorders

Clinical Genetics, EarlyView.
Avascular Necrosis (AVN) and Minimal Trauma Fractures (MTF) cause significant morbidity in people with Telomere Biology Disorders (TBDs). They occur more frequently in young patients and in those with autosomal recessive (AR) or X‐linked recessive (XLR) than in autosomal dominant (AD) genotypes.
Arman M. Niknafs, Neelam Giri, Marena R. Niewisch, Sharon A. Savage   +3 more
wiley   +1 more source

Oral bisphosphonate-associated osteonecrosis of maxillary bone: a review of 18 cases [PDF]

, 2014
Biphosphonate-associated maxillary bone osteonecrosis (BPMO) is a complication related to nitrogen-containing biphosphonate therapy. This adverse effect occasionally appears in patients who are administered biphosphonates through intravenous infusion for
Escovich, Livia, López D'alessandro, Edgardo, Mardenlli, Fabiana, Paz, Marisa   +3 more
core   +1 more source

Odanacatib Coating Supports Osseointegration of Implants: A Preclinical Study

Clinical Oral Implants Research, EarlyView.
ABSTRACT Introduction Odanacatib (ODN), a cathepsin K inhibitor, is a drug that reduces bone resorption while preserving bone formation. ODN was initially developed for the treatment of postmenopausal osteoporosis, but further development as a systemic medication has been discontinued.
Natália dos Santos Sanches, Caroline Liberato Marchiolli, Lara Cristina Cunha Cervantes, Maria Cristina Ruiz Voms Stein, Sara Alves Berton, Estéfany Lopes Lemes do Prado, Carina Kampleitner, Francisley Ávila Souza, Roberta Okamoto, Reinhard Gruber, Idelmo Rangel Garcia Júnior   +10 more
wiley   +1 more source